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Abstract
Background:We aimed to calculate 3-year incidence of multimorbidity, defined as the development of two or more chronic
diseases in a population of older people free from multimorbidity at baseline. Secondly, we aimed to identify predictors of
incident multimorbidity amongst life-style related indicators, medical conditions and biomarkers.
Methods: Data were gathered from 418 participants in the first follow up of the Kungsholmen Project (Stockholm, Sweden,
1991–1993, 78+ years old) who were not affected by multimorbidity (149 had none disease and 269 one disease), including
a social interview, a neuropsychological battery and a medical examination.
Results: After 3 years, 33.6% of participants who were without disease and 66.4% of those with one disease at baseline,
developed multimorbidity: the incidence rate was 12.6 per 100 person-years (95% CI: 9.2–16.7) and 32.9 per 100 person-
years (95% CI: 28.1–38.3), respectively. After adjustments, worse cognitive function (OR, 95% CI, for 1 point lower Mini-
Mental State Examination: 1.22, 1.00–1.48) was associated with increased risk of multimorbidity among subjects with no
disease at baseline. Higher age was the only predictor of multimorbidity in persons with one disease at baseline.
Conclusions: Multimorbidity has a high incidence at old age. Mental health-related symptoms are likely predictors of
multimorbidity, suggesting a strong impact of mental disorders on the health of older people.
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Introduction
During the last two decades, research on multimorbidity,
defined as the coexistence of a number of chronic diseases in the
same individual, has rapidly increased. As chronic conditions are
strongly related to aging, the majority of studies focused on the
elderly population. However, since now, only selected aspects of
multimorbidity were investigated, such as prevalence and conse-
quences of co-existing diseases [1]. These previous reports have
clearly shown that multimorbidity affects a large proportion of
older persons ranging from 55 to 98% across studies depending on
definition, age of the population and data source [2,3]. It has been
established that there is a clear association between increasing
number of chronic diseases and disability [4–6], poor quality of life
[6,7] and high health care utilization [8,9].
Development of multimorbidity and identification of possible
predictors of multimorbidity has been explored in few studies,
which showed that 1-year incidence of multimorbidity (defined as
2 or more new diseases) was 1.3% in the whole population
including all ages [10]. A few possible risk factors for multi-
morbidity were identified, such as increasing age [10] and a low
socioeconomic status [10–12], whereas a large social network
seemed to play a protective role [13]. Recently, the mediating role
of smoking and body mass index (BMI) on the educational effect
was detected in a German population [11].
In the current study, we aimed to estimate the incidence of
multimorbidity, and to identify possible predictors for multi-
morbidity. Several factors were evaluated, including life-style
related factors, medical conditions and biomarkers. As the effect of
these factors may depend on the health status of a person, we
stratified participants at baseline according to presence or absence
of one chronic disease.
Methods
Study design and participants
This study gathered data from the Kungsholmen Project (KP),
which is a cohort study on aging and dementia carried out in
Stockholm, Sweden, in a population of 75 years and older subjects
(n = 2368) [14]. The KP was approved by the ethics committee of
the Karolinska Institute. Each participant signed a written
informed consent. The current study used as sample the 418
participants in the first KP follow up (1991–1993) who were living
independently and were not affected by multimorbidity. Among
them, 149 did not have any chronic disease and 269 were affected
by only one chronic disease. After 3-year follow-up, 28 partic-
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ipants refused to be re-assessed; thus complete data on 390 persons
were available for analysis (140 without any chronic disease and
250 with one disease).
Data collection
At all examinations in the KP the data were collected following
the same standardized protocols, including a social interview, a
neuropsychological battery and a medical examination [14]. Blood
samples were obtained for several laboratory tests. The elderly and
their next-of-kin were interviewed by trained nurses using a
structured questionnaire on living conditions and social status.
Chronic diseases
A disease was classified as chronic if it satisfied one of the
following criteria: 1. being permanent, 2. caused by non-reversible
pathological alteration, 3. requiring rehabilitation, or 4. requiring
a long period of care. Chronic conditions were assessed using
multiple sources [2]: the diagnoses made by the physicians at each
assessment in the KP assessments using data from medical history
and medication use, clinical examination, and laboratory testing,
and the computerized Stockholm Inpatient Registry. The inpa-
tient registry encompasses all hospitals in the Stockholm area since
1969, and records up to six diagnoses at discharge. To increase
completeness of the data on the presence or absence of each
disease, in addition to this information we used the ATC [18]
coded medication data to establish the presence of cancer,
depression, diabetes, hypertension, Parkinson’s disease, and
thyroid disease from the use of medication only prescribed for
these specific conditions. Also, we used the laboratory data on
hemoglobin to establish the presence of anemia using an algorithm
classifying males with Hb of ,13 g/l and females with Hb of ,
12 g/l as anemic according to WHO criteria [19]. Dementia
diagnoses were made using the DSMIII-R criteria by a senior
neurologist, and the diagnosis of a major depression by a
psychiatrist according to DSM-IV [20,21]. The list of chronic
diseases included in the calculation of multimorbidity is shown in
(Table S1).
Of the 390 study participants included in these analyses, 86
persons (20 of 149 without disease and 66 of 269 with one disease
at baseline) died before the follow-up assessment and for these
individuals the presence of multimorbidity was calculated on the
basis of the inpatient registry data only.
Incident multimorbidity
Multimorbidity was the primary outcome measure in this study
and was defined as any co-occurrence of two or more chronic
conditions in the same individual, whether coincidental or not
[10]. Incident cases were defined as subjects with no or only one
chronic disorder at baseline who developed at least another
chronic disease during the 3-year follow-up.
Possible predictors of multimorbidity
We examined the following variables:
– Social demographic measures: age (years), sex, living situation,
living arrangement, and education. Education was measured
by the maximum years of formal schooling, and this variable
was dichotomized ($8 versus ,8 years) according to our
previous study [2]. Living arrangement was dichotomized into
living alone or living with others.
Lifestyle related factors: physical activity, smoking, and alcohol
drinking. Physical activity was assessed approximately three years
before the baseline of the current study, and was dichotomized in
the analyses into ‘no physical activity’ and ‘at least weekly physical
activity’. Smoking was operationalized in the analyses in three
classes. Alcohol drinking was operationalized in the analyses as
‘less than 1 unit per week’, ‘between 1 and 7 units per week’, and
‘7 or more units per week’.
– Physical examination variables: Body Mass Index (BMI, kg/
m2), heart rate (beats/min), blood pressure (mmHg), and the
six Katz items on Activities of Daily Living [15];
– Laboratory findings: hemoglobin (Hb, g/l), albumin (Alb, g/l),
erythrocyte sedimentation rate (ESR, mm/hour), and white
blood cell count (WBC, *109 leukocytes/l);
– Affective and cognitive scales: the Comprehensive Psychopath-
ological Rating Severity scale for mood related and motivation
related symptoms of depression (CPRS, range 0-48, where
higher score indicates more symptoms; [16]); global cognition
using the Mini Mental State Examination (MMSE, range 0-30,
where higher score indicate better cognition; [17]). CPRS is a
structured psychiatric interview with both directed questions
and observations. The CPRS severity subscale for mood-
related symptoms assesses the following four symptoms on a
scale from 0-6: dysphoria, appetite disturbance, feelings of
guilt, and thoughts of death. The severity subscale for
motivation-related symptoms assesses: lack of interest, psycho-
motor change, loss of energy, and concentration difficulties,
again scoring 0-6 per item. If the participant was not able to
answer the questions reliably, an informant was contacted.
Statistical analysis
Using descriptive statistics the baseline characteristics were
presented grouping the participants according to the presence of
no or one chronic disease. Cumulative incidence for multi-
morbidity was calculated by the number of new cases of
multimorbidity during the follow-up period divided by the number
of subjects at risk in the population at the beginning of the study
and not lost to follow up due to withdrawal of informed consent;
95% confidence intervals were calculated according to the
binomial distribution. Multimorbidity incidence rates were calcu-
lated as the number of new cases of multimorbidity divided by the
total person-time observed between the two assessments or until
date of death. Exact Poisson rate 95% confidence intervals were
calculated. Logistic regression analysis was used to study the effect
of the possible predictors of multimorbidity, starting with
univariate analyses checking the effect of each variable separately,
followed by bivariate analyses taking into account the effect of the
presence of one disease at baseline and next by adding an
interaction term between the predictor of interest and the presence
of one disease. Since the interaction analyses showed that the
presence of disease at baseline was likely an effect modifier, the
multivariate analyses were stratified for the presence or absence of
disease at baseline. All missing values in the variables that were
used in the analyses for this study – potential predictors as well as
the dependent variables – were imputed twenty times assuming a
multivariate normal distribution of the data using SAS Proc MI
and SAS Proc MIANALYZE to calculate measures of precision.
All results reported in this paper are based on the imputed
datasets. A series of sensitivity analyses were run.
Results
At baseline 418 participants were living independently and were
not affected by multimorbidity. As 28 subjects refused the follow-
up assessment, 390 participants were included in the analysis: of
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these, 140 participants had no disease and 250 participants had
one disease at the baseline (Table 1). After three years, among the
140 participants who were without any chronic disease at baseline
50 (35.7%; 95% CI = 27.8–43.7) still were without disease, 43
(30.7%; 95% CI = 23.1–38.4) had one disease and 47 (33.6%;
95% CI = 25.8–41.4) developed multimorbidity. The 3-year
cumulative incidence for multimorbidity in this group was
33.6%. In the subgroup of the 250 participants with one disease
at baseline, 22 (8.8%; 95% CI = 5.3–12.3) were without morbidity,
62 (24.8%; 95% CI = 19.5–30.2) still have one disease and 166
(66.4%; 95% CI = 60.5–72.3) developed multimorbidity. The 3-
year cumulative incidence for multimorbidity in this group was
66.4%. The incidence rate was 12.6 per 100 person-years (95%
CI: 9.2–16.7) and 32.9 per 100 person-years (95% CI: 28.1–38.3),
respectively. Further, we calculated the incidence rates separately
for the two subgroups (subjects with one or no chronic disease at
baseline), and stratified by gender and age. Results are reported in
Figure 1. The risk of developing multimorbidity was higher among
subjects with one disease and older people; no substantial gender
differences were detected.
In the univariate models several factors were associated with an
increased relative odd of incident multimorbidity at follow up in
the whole group of 390 participants (Table 2). As already said in
the methods, the interaction between potential predictors of
incident multimorbidity and the presence of one disease at
baseline was statistically significant for almost all variables. Thus,
all analyses were run after stratification for absence or presence of
one disease at baseline.
The multivariate models combined potential predictors, and
confounders as they were derived from the univariate analyses and
the analyses were stratified for the presence or absence of one
disease at baseline (Table 3). In the final multivariate adjusted
model for persons without any disease at baseline, global cognition
(MMSE) was significantly (OR 1.22, 95% confidence interval
1.00–1.48, p = 0.05) related to multimorbidity occurrence and
mood (CPRS) almost (OR 1.18, 95%-CI 0.99–1.40, p = 0.06). In
the multivariate adjusted model for persons with already one
disease at baseline, only higher age was significantly related to
multimorbidity incidence at follow up (table 3; OR 1.09, 1.01–
1.17, p = 0.03). No further statistically significant predictors of
multimorbidity incidence were identified in this stratum, however,
drinking less than 1 unit of alcohol per week was associated with
an OR of 1.87 (0.98–3.58) at p = 0.06.
Sensitivity analysis
As global cognition (MMSE) and mood (CPRS) turned out to be
likely predictors of multimorbidity, we reran the analyses with
dementia and depression not counted for the incidence of
multimorbidity at follow up in order to rule out the effect of these
two predictors. The results showed that the correlations of MMSE
and CPRS score with multimorbidity were comparable. The
association with MMSE diminished slightly to OR 1.15 (0.93–
1.41, p = 0.19). The association with CPRS increased slightly: OR
1.20 (1.00–1.44, p = 0.05). Further, we calculated the associations
of MMSE quartile scores as categorical variable with multi-
moribidity occurrence (best performing quartile as the reference
group) for the two subgroups with and without morbidity at
baseline. These results suggest that it is perhaps the two lowest
quartiles (an MMSE below 27) that have the strongest association
with multimorbidity occurrence in the group without disease at
baseline (Table S2).
Discussion
A systematic review of the literature on multimorbidity [1]
identified very few prospective studies which evaluated incidence
and predictors of multimorbidity. In the present study, we used
data on the older population enrolled in the Kungsholmen Project
to quantify the incidence of multimorbidity over a period of three
years. In this 78+ year-old population, multimorbidity had a high
incidence as it developed with a rate of approximately 12 per 100
person-years in people not affected by any chronic disorders and
33 per 100 person-years in those with already one disease at
baseline. Secondly, among the few factors identified as possible
predictors of multimorbidity onset, clinical symptoms related to
mental disorders emerged as the most important factors to identify
people at risk to develop multimorbidity among subjects without
any disease. Lower cognitive abilities and perhaps also increasing
number of depression-related symptoms predicted the develop-
ment of multimorbidity in persons with no disease at baseline.
Among participants with already one disease, only age was a
predictor of multimorbidity incidence.
In 1998, van den Akker and colleagues reported that cumulative
incidence of multimorbidity, defined as 2 or more new diagnoses
during one year, was 1.3% in the general population (all ages) but
.5% in those aged 80 and older [10]. However, the authors did
not select persons according to the presence of none or one plus
disease at baseline. In our study, the cumulative incidence of
multimorbidity in very old elderly differed depending on the
absence or presence of one disease at baseline. In fact, two third of
participants affected by already one disease became multimorbid
after only 3 years compared to one third of those without any
disease. Anyhow even taking into account this last group, the
estimates of annual cumulative incidence and the incidence rates
were double higher than those reported by van den Akker [10].
Dissimilarities in the diagnoses recording (van den Akker evaluated
multimorbidity in a general practice setting) may explain this
difference.
Despite the fact than more than 50% of 75+ old subjects are
affected by multimorbidity, little research has focused on risk
factors and predictors of this syndrome. A couple of papers focused
on the impact of socioeconomic status on the development of
multimorbidity [11,22]. Childhood financial hardship and lifetime
earnings were associated with multimorbidity being the latter a
protective factor [22] and lower education was associated with
multimorbidity [11]. In this study using data from the Kungshol-
men population that is over age 75 we found that education, which
is a good indicator of SES, education was positively associated with
incident multimorbidity, although without reaching statistical
significance, especially in participants with no disease at baseline.
In the Kungsholmen Project, data on another indicator of SES
were collected, e.g. lifetime occupation. Due to the high
correlation between occupation-based SES and education in this
population we did not use the occupation variable in the present
study. In fact, previous analyses on prevalent multimorbidity in the
Kungsholmen Project showed that occupation-based SES had a
crude association with multimorbidity, but not when adjusted for
education. Besides, low education showed a strong association with
multimorbidity independent of high or low occupation-based SES
[2].
We found that at higher age cognition and depressive symptoms
were possible predictors of multimorbidity onset in people who
were without significant chronic morbidity at baseline. In the older
population, depressive symptoms are commonly associated with
chronic medical conditions. The finding was confirmed – even
strengthened slightly – when we excluded depression diagnosis
Incidence and Predictors of Multimorbidity
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Figure 1. Multimorbidity (two or more diseases) incidence rates (95% confidence intervals) for participants without and with one
disease at baseline (black) and by sex (grey) and age category (young old: ,85 years and old old: $85 years, white).
doi:10.1371/journal.pone.0103120.g001
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from the multimorbidity definition. Depression can delay diagnosis
of other diseases and negatively affect medication adherence and
healthy behaviors to prevent other clinical conditions [23].
Moreover, depressive symptoms may lead to social isolation.
Van den Akker and colleagues found that living in a family
compared to living alone and a large social network were
protective factors for multimorbidity occurrence [13]. This result
is consistent with previous studies showing that older age
depression was associated with several adverse outcomes if not
adequately treated, such as increased risk of disability, poor quality
of life and mortality [24,25]. On the other hand, chronic diseases
increase the risk of depression, with the prevalence of depression
being up to five times higher in persons with chronic medical
conditions [26]. This strong association can be explained by the
presence of disability, pain and polypharmacy in the elderly
affected by multiple diseases. In this study, depressive symptoms
were measured three years before the diagnosis of multimorbidity,
thus the possibility of such reverse causation seems unlikely.
Finally, the mechanism linking depressive symptoms to incident
multimorbidity may be chronic inflammation. In fact, several
studies have shown higher circulating pro-inflammatory cytokines
levels in depressive disorders [27]. Unfortunately, in the Kungshol-
men Project such markers of inflammation were not available.
Further, a worse MMSE was a predictor of the occurrence of
multimorbidity in those participants free from any disease. So far,
cognitive impairment has mainly been studied as a consequence of
several chronic diseases and also of multimorbidity [28]. Previous
cross-sectional and longitudinal studies reported a positive
association between poor health and multimorbidity and cognitive
complaints or impairment [29,30]. In our study, worse cognition
measured three years before the multimorbidity assessment was
associated with the development of multimorbidity. It is possible
Table 1. Baseline characteristics of the participants according to the presence/absence of one chronic disease.
No chronic disease n=140 One chronic disease N=250
Age (year), mean (sd) 83.3 (3.7) 84.2 (4.2)
Female, n (%) 102 (73) 190 (76)
Low education (,8 years), n (%) 58 (42) 110 (44)
MMSE, mean (sd) 27 (2) 26 (4)
Living alone*, n (%) 102 (73) 179 (72)
At least one ADL disability, n (%) 21 (15) 58 (23)
Physically active, n (%) 30 (21) 28 (11)
Smoking, n (%)
Non-smoker 83 (61) 141 (62)
Former smoker 24 (18) 59 (26)
Current smoker 29 (21) 27 (12)
Alcohol drinking, n (%)
,1 unit/week 88 (63) 165 (69)
1–6 units/week 48 (35) 66 (28)
$7 units/week 4 (3) 7 (3)
Body Mass Index, n (%)
,18.5 kg/m2 6 (5) 16 (8)
18.5–25 kg/m2 93 (75) 127 (64)
.25 kg/m2 25 (20) 57 (29)
Heart rate, n (%)
#60 bpm 20 (14) 26 (11)
61–100 bpm 115 (83) 214 (87)
$100 bpm 3 (2) 6 (2)
Diastolic blood pressure (mmHg), mean (sd) 80 (11) 81 (11)
Systolic blood pressure (mmHg), mean (sd) 158 (20) 160 (21)
CPRS, mean (sd) 2.1 (2.4) 2.1 (2.8)
Hemoglobin (g/l), mean (sd) 138 (9) 137 (13)
WBC (*109 leucocytes/l), mean (sd) 6.5 (1.5) 6.9 (2.1)
ESR (mm/hour), mean (sd) 16 (14) 19 (15)
Albumin (g/l), mean (sd) 42.2 (2.3) 42.3 (2.8)
*As opposed to living independently but with others.
ADL, Activities of Daily Living (measured with Katz ADL, 0–6, higher score indicates worse function).
CPRS, Comprehensive Psychopathological Rating Severity (0–48, higher score indicates more depressive symptoms).
ESR, Erythrocyte Sedimentation Rate.
MMSE, Mini-Mental State Examination (0–30, higher score indicates better function).
WBC, white blood cell.
doi:10.1371/journal.pone.0103120.t001
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that cognitive decline is a manifestation of a latent and still
undiagnosed chronic disease such as low oxygen levels in chronic
respiratory diseases, insulin imbalance in diabetes, and thyroid
hormone deficiency or excess in thyroid dysfunction may have
already affected the brain [31]. Silent brain infarction may also be
present. Another explanation is that cytokine activated immune
system dysregulation as well as chronic stress, both frequent in the
elderly, may affect first the brain and secondly the body through
the imbalance of the adrenocortico axis [32]. Finally, the same
disease pathology or risk factors may lead to both cognitive
impairment and specific chronic disease; for example estrogen
deficiency may be associated with both cognitive impairment and
osteoporosis.
Among characteristics that we did not find associated with
incident multimorbidity, there were some life-style factors usually
correlated with chronic diseases, such as smoking and alcohol.
Indeed, the leading chronic-disease causes of death can be
attributed to tobacco use and alcohol consumption beyond
physical inactivity [33]. Our findings may be due to a survival
effect. In fact, subjects who are continuous smokers have a high
mortality risk and many of them probably died before the
enrolment in the present study. The lack of the expected
association of alcohol intake with multimorbidity can be also
being due to the common underrating of alcohol intake in
interviews. Remarkably, in people who had one disease at baseline
already, drinking less than one unit of alcohol per week was
associated with an increased occurrence of multimorbidity three
years later as compared to moderate drinkers. We want to be
cautious interpreting this finding, however, it could be that non-
drinkers actually stopped drinking due to their health condition.
Thus, they might be at higher risk for increasing disease burden
than moderate drinkers. It has been suggested that moderate
‘‘alcohol consumption may represent a marker of higher social
level [and] superior health status’’ [34].
Table 2. The crude odds ratios (OR) and 95% confidence intervals (95% CI) of potential predictors for multimorbidity separately for
the two subgroups of people with no or one disease at baseline.
Predictor of interest No chronic disease at baseline (n=140) One chronic disease at baseline (n=250)
OR (95% CI)* OR (95% CI)*
Age (years, continuous) 1.00 (0.91–1.10) 1.08 (1.01–1.16)**
Sex (female vs male) 1.34 (0.60–3.01) 0.73 (0.38–1.37)
Education (low vs high education) 1.81 (0.89–3.69) 1.22 (0.72–2.08)
Living alone vs living with other 1.34 (0.60–3.01) 1.06 (0.59–1.90)
Katz ADL (number of disabilities, continuous) 0.76 (0.27–2.11) 1.29 (0.85–1.94)
Hemoglobin (g/l, continuous) 0.97 (0.93–1.01) 1.00 (0.98–1.02)
ESR (mm/hour, continuous) 1.05 (1.01–1.08)** 1.01 (0.99–1.03)
WBC* (109 leucocytes/l, continuous) 1.18 (0.92–1.51) 1.08 (0.94–1.25)
Albumin (g/l, continuous) 1.05 (0.90–1.21) 0.97 (0.88–1.07)
Heart rate
#60 vs 60–99 bpm 1.81 (0.69–4.75) 0.97 (0.41–2.28)
$100 vs 60–99 bpm 4.18 (0.37–47.66) 1.07 (0.19–5.98)
Diastolic blood pressure (increase of 10 mmHg) 0.71 (0.49–1.03)*** 0.91 (0.72–1.16)
Systolic blood pressure (increase of 10 mmHg) 0.92 (0.77–1.11) 0.99 (0.88–1.12)
Physical activity (yes vs no) 0.42 (0.16–1.11)*** 1.30 (0.55–3.09)
Depressive symptoms (CPRS, continuous) 1.16 (1.00–1.35)** 1.04 (0.94–1.15)
Worse cognitive abilities (MMSE, continuous) 1.25 (1.06–1.48)** 1.06 (0.99–1.14)***
Smoking (3 categories: never, former, current, continuous) 0.92 (0.59–1.43) 1.14 (0.77–1.70)
Alcohol drinking
,1 unit/week vs 1–6 units/week 1.02 (0.48–2.17) 1.89 (1.05–3.40)**
$7 units/week vs 1–6 units/week 19.44 (0.70–538.9)*** 3.85 (0.52–28.4)
BMI
,18.5 vs 18.5–25 kg/m2 1.07 (0.20–5. 78) 0.93 (0.31–2.76)
.25 vs 18.5–25 kg/m2 1.26 (0.49–3.25) 1.26 (0.69–2.38)
*the odd ratios presented are for the continuous and ordinal variables the odds ratio for an increase of one unit/level unless stated otherwise and for the dichotomized
variables for presented dichotomy.
**p,0.05.
***p,0.10.
ADL, activities of daily living (0–6, higher score indicates worse function).
CPRS, Comprehensive Psychopathological Rating Severity (0–48, higher score indicates more depressive symptoms).
BMI, Body Mass Index.
ESR, erythrocyte sedimentation rate.
MMSE, mini-mental state examination (0–30, higher score indicates better function).
WBC, white blood count.
doi:10.1371/journal.pone.0103120.t002
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Limitations
Because of the study design, characteristics of the patients were
assessed only in a single measurement at baseline. Some factors,
such as physical activity, are considered relatively stable, but they
can change over time, especially as a result of a disease. In line
with previous studies [12,35], a follow-up time of three years was
chosen for the calculation of incident cases. In fact, distribution of
diseases is not random in time, but disease susceptibility is
markedly different according to the duration of the follow-up
interval, and the stability of several individual characteristics over
time is not known [12]. Second, we pre-selected a list of 39 chronic
diseases, thus automatically excluding some others (although rare);
moreover, for a number of participants we had to rely only on
hospital registry information, which may differ in some way from
those who were seen by the study physician for a second time,
although this is also a strength for those who died in between
intervals and could still be included thanks to the registry
information.
Conclusions
Multimorbidity has a high incidence in the elderly, especially in
those with already one disease at baseline. Worse cognition and
low mood emerged as possible predictors of development of
multimorbidity, suggesting a strong influence of mental disorders
on the health of older people. Due to increasing life expectancy,
prevalence of chronic diseases is expected to increase in the near
future [36]. The coexistence of multiple chronic diseases has been
found to be associated with several adverse outcomes as well as
high medical care costs. Identifying at risk subjects to develop
multimorbidity may help to implement prevention strategies
among older people.
Supporting Information
Table S1 List of chronic diseases included in the
calculation of multimorbidity (chronic diseases present
at least once in the complete KP cohort of participants
who participated in the first follow up).
(DOCX)
Table S2 The crude odds ratios (OR) and 95% confi-
dence intervals (95% CI) of MMSE quartile scores for
multimorbidity separately for the two subgroups of
people with no or one disease at baseline with the people
in Q1 (MMSE 29–30) as reference category (on unim-
puted dataset, because there were no missings for the
variables involved).
Table 3. Association between potential predictors and the incidence of multimorbidity in persons with and without one chronic
disease at baseline.
Predictors of interest No chronic disease at baseline (n =140) One chronic disease at baseline (n =250)
OR (95% CI)* OR (95% CI)*
Age (years, continuous) 0.99 (0.89–1.11) 1.09 (1.01–1.17)**
Sex (female vs male) 0.87 (0.30–2.52) 0.88 (0.42–1.87)
Education (low vs high education) 1.36 (0.56–3.32) 0.94 (0.51–1.75)
Katz ADL (number of disabilities, continuous) 0.80 (0.25–2.60) 1.01 (0.64–1.60)
Hemoglobin (g/l, continuous) 0.98 (0.93–1.03) 1.01 (0.99–1.04)
ESR (mm/hour, continuous) 1.02 (0.99–1.06) 1.02 (0.99–1.04)
WBC (*109 leucocytes/l, continuous) 1.19 (0.89–1.58) 1.06 (0.92–1.22)
Diastolic blood pressure (increase of 10 mmHg) 0.98 (0.94–1.01) 0.99 (0.96–1.02)
Physical activity (yes vs no) 0.44 (0.15–1.28) 1.55 (0.61–3.92)
Depressive symptoms (CPRS, continuous) 1.18 (0.99–1.40)*** 1.03 (0.93–1.14)
Worse cognitive abilities (MMSE, continuous) 1.22 (1.00–1.48)** 1.04 (0.96–1.12)
Smoking (3 categories: never, former, current,
continuous)
0.86 (0.49–1.52) 1.29 (0.80–2.07)
Alcohol drinking
,1 unit/week vs 1–6 units/week 0.90 (0.36–2.22) 1.87 (0.98–3.58)***
$7 units/week vs 1–6 units/week 11.43 (0.37–348.43) 2.89 (0.36–22.97)
BMI
,18.5 kg/m2 vs 18.5–25 kg/m2 1.30 (0.11–7.98) 0.95 (0.30–3.03)
.25 kg/m2 vs 18.5–25 kg/m2 1.48(0.47–4.71) 1.33 (0.68–2.60)
Odds Ratio (OR) and 95% confidence intervals (95% CI) from multivariate logistic regression models.
*the odd ratios presented are for the continuous and ordinal variables the odds ratio for an increase of one unit/level unless stated otherwise and for the dichotomized
variables for presented dichotomy.
**p,0.05.
***p,0.10.
ADL, activities of daily living (0–6, higher score indicates worse function).
BMI, Body Mass Index.
CPRS, Comprehensive Psychopathological Rating Severity (0–48, higher score indicates more depressive symptoms).
ESR, erythrocyte sedimentation rate.
MMSE, mini-mental state examination (0–30, higher score indicates better function).
WBC, white blood count.
doi:10.1371/journal.pone.0103120.t003
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